Cited by 65Dementia and Cognitive Impairment ResearchAlzheimer's disease research and treatmentsSchizophrenia research and treatment

Psychosis in Alzheimer's disease is associated with frontal metabolic impairment and accelerated decline in working memory: findings from the Alzheimer's Disease Neuroimaging Initiative

Koppel, Jeremy, Sunday, Suzanne, Goldberg, Terry E., Davies, Peter, Christen, Erica, Greenwald, Blaine S.·2014·The American Journal of Geriatric Psychiatry

Abstract

Objective An ascendant body of evidence suggests that Alzheimer disease with psychosis (AD+P) is a distinct variant of illness with its own genetic diathesis and a unique clinical course. Impaired frontal lobe function has been previously implicated in AD+P. The current exploratory study, presented in two parts, evaluates both the regional brain metabolic and psychometric correlates of psychosis in a longitudinal sample of subjects with AD, made available by the Alzheimer's Disease Neuroimaging Initiative (ADNI).Methods In Part 1 of the study, 21 ADNI participants with AD who developed psychotic symptoms during the study but were not psychotic at baseline were matched with 21 participants with AD who never became psychotic during the study period, and mean brain [F(18)]fluorodeoxyglucose positron emission tomography (FDG-PET) Cerebral metabolic rate for glucose (CMRgl) by regions of interest (ROIs) were compared Additionally, 39 participants with active psychosis at the time of image acquisition were matched with 39 participants who were never psychotic during the study period, and mean brain FDG-PET CMRgl by sROI were compared. In Part 2 of the study, 354 ADNI participants with AD who were followed for 24 months with serial psychometric testing were identified, and cognitive performance and decline were evaluated for correlation with psychotic symptoms.Results Part 1: There were no regional brain metabolic differences between those with AD destined to become psychotic and those who did not become psychotic. There was a significant reduction in mean orbitofrontal brain metabolism in those with active psychosis. Part 2: Over the course of study follow-up, psychosis was associated with accelerated decline in functional performance as measured by the Functional Assessment Questionnaire, the Mini-Mental State Examination, and Forward Digit Span.Conclusion In a sample drawn from the ADNI dataset, our exploratory FDG-PET findings and longitudinal cognitive outcomes support the hypofrontality model of AD+P. Focal frontal vulnerability may mediate the accelerated decline seen in AD+P.

Integrity signals

Registry

Crossref · 10.1016/j.jagp.2012.10.028

Cites

41 of 41 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • Delusions in Alzheimer's disease are associated with decreased gray matter volume, perfusion or metabolism in frontal cortex and anterior cingulate cortex.

    “Delusions were associated with decreased gray matter (GM) volume, perfusion or metabolism in frontal cortex and ACC (Bruen et al., 2008; Koppel et al., 2014; Mega et al., 2000; Nakaaki et al., 2013; Rafii et al., 2011; Sultzer et al., 2003; Whitehead et al., 2012).”

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Authors
Koppel, J., Sunday, S., Goldberg, T. E., Davies, P., Christen, E., & Greenwald, B. S.
Corresponding author
Koppel, Jeremy
Venue
The American Journal of Geriatric Psychiatry
Publisher
Elsevier BV
Published
2014-07
Volume
22
Issue
7
Pages
698-707
ISSN
1064-7481 (ISSN-L)
OpenAlex
W2046090892
Cited by
65
References
41
Citations by year
2026: 2 · 2025: 1 · 2024: 6 · 2023: 1 · 2022: 6 · 2021: 4 · 2020: 6 · 2019: 6 · 2018: 7 · 2017: 6 · 2016: 5 · 2015: 6 · 2014: 7 · 2013: 2
FWCI
4.72
Type
journal article
Language
en
Open access
closed
Locations
  • American Journal of Geriatric Psychiatry (publishedVersion)
  • PubMed (publishedVersion)
Funders
  • National Institutes of Health (5u01ag024904-10)
  • National Institute on Aging (U01-AG-024904, P30AG010129, K01AG030514)
Topics
  • Health Sciences › Medicine › Psychiatry and Mental health › Dementia and Cognitive Impairment Research
  • Health Sciences › Medicine › Physiology › Alzheimer's disease research and treatments
  • Health Sciences › Medicine › Psychiatry and Mental health › Schizophrenia research and treatment
Keywords
frontal lobe hypometabolism, orbitofrontal cortex, brain glucose metabolism, FDG-PET, cognitive decline, functional performance
MeSH terms
Aged, Alzheimer Disease, Female, Frontal Lobe, Glucose, Humans, Longitudinal Studies, Male, Memory Disorders, Memory, Short-Term, Neuropsychological Tests, Psychotic Disorders, Case-Control Studies, Fluorodeoxyglucose F18, Positron-Emission Tomography, Functional Neuroimaging

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review